标题
Fasting and rapamycin: diabetes versus benevolent glucose intolerance
作者
关键词
-
出版物
Cell Death & Disease
Volume 10, Issue 8, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-08-13
DOI
10.1038/s41419-019-1822-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Calorie restriction for long-term remission of type 2 diabetes
- (2019) Roy Taylor CLINICAL MEDICINE
- Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice
- (2018) Roxanne Weiss et al. Aging-US
- A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors
- (2018) Amikar Sehdev et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Rapamycin improves insulin resistance and hepatic steatosis in type 2 diabetes rats through activation of autophagy
- (2018) Wan Zhou et al. CELL BIOLOGY INTERNATIONAL
- Mechanisms by which a Very-Low-Calorie Diet Reverses Hyperglycemia in a Rat Model of Type 2 Diabetes
- (2018) Rachel J. Perry et al. Cell Metabolism
- mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells
- (2018) Amin Ardestani et al. Cell Metabolism
- A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects
- (2018) Ellen Kraig et al. EXPERIMENTAL GERONTOLOGY
- Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial
- (2018) Zhi-Wei Lai et al. LANCET
- Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
- (2018) Michael EJ Lean et al. LANCET
- TORC1 inhibition enhances immune function and reduces infections in the elderly
- (2018) Joan B. Mannick et al. Science Translational Medicine
- Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery
- (2018) Roy Taylor et al. Cell Metabolism
- Chronic oral rapamycin decreases adiposity, hepatic triglycerides and insulin resistance in male mice fed a diet high in sucrose and saturated fat
- (2018) Laura J. den Hartigh et al. EXPERIMENTAL PHYSIOLOGY
- Short-term feeding of a ketogenic diet induces more severe hepatic insulin resistance than a obesogenic high-fat diet
- (2018) Gerald Grandl et al. JOURNAL OF PHYSIOLOGY-LONDON
- Disease or not, aging is easily treatable
- (2018) Mikhail V. Blagosklonny Aging-US
- Lipid sensing by mTOR complexes viade novosynthesis of phosphatidic acid
- (2017) Deepak Menon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dietary guidelines in type 2 diabetes
- (2017) Ola K. Magnusdottir et al. Current Opinion in Endocrinology Diabetes and Obesity
- A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs
- (2017) Silvan R. Urfer et al. GeroScience
- Risk of hyperglycemia attributable to everolimus in cancer patients: A meta-analysis
- (2016) Kevin Y. Xu et al. ACTA ONCOLOGICA
- Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes
- (2016) Peter C. Reifsnyder et al. Aging-US
- Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials
- (2016) Petri Bono et al. Clinical Genitourinary Cancer
- Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders
- (2016) Sarah Steven et al. DIABETES CARE
- Ketogenic diets: from cancer to mitochondrial diseases and beyond
- (2016) Ana F. Branco et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice
- (2016) Sebastian I. Arriola Apelo et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Weight loss induced by very low calorie diet is associated with a more beneficial systemic inflammatory profile than by Roux-en-Y gastric bypass
- (2016) Mirjam A. Lips et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Rapamycin/GABA combination treatment ameliorates diabetes in NOD mice
- (2016) Sirong He et al. MOLECULAR IMMUNOLOGY
- Growth and aging: a common molecular mechanism
- (2016) Mikhail V. Blagosklonny et al. Aging-US
- Intermittent supplementation with rapamycin as a dietary restriction mimetic
- (2016) Valter D Longo et al. Aging-US
- Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to
- (2016) Mikhail V. Blagosklonny Aging-US
- Rapamycin-induced metabolic defects are reversible in both lean and obese mice
- (2016) Yuhong Liu et al. Aging-US
- Metabolic consequences of long-term rapamycin exposure on common marmoset monkeys (Callithrix jacchus)
- (2015) Corinna Ross et al. Aging-US
- Manipulation of health span and function by dietary caloric restriction mimetics
- (2015) George S. Roth et al. Annals of the New York Academy of Sciences
- The Roles of mTOR Complexes in Lipid Metabolism
- (2015) Alexandre Caron et al. Annual Review of Nutrition
- Restoring normoglycaemia by use of a very low calorie diet in long- and short-duration Type 2 diabetes
- (2015) S. Steven et al. DIABETIC MEDICINE
- Rapamycin Increases Mortality indb/dbMice, a Mouse Model of Type 2 Diabetes
- (2015) Kavithalakshmi Sataranatarajan et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Rapamycin Versus Intermittent Feeding: Dissociable Effects on Physiological and Behavioral Outcomes When Initiated Early and Late in Life
- (2015) Christy S. Carter et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Acute Sirolimus Overdose: A Multicenter Case Series
- (2015) Alessandro Ceschi et al. PLoS One
- Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet
- (2014) Olga V. Leontieva et al. AGING CELL
- Long-term ketogenic diet causes glucose intolerance and reduced β- and α-cell mass but no weight loss in mice
- (2014) Johanne H. Ellenbroek et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†
- (2014) M. Piccart et al. ANNALS OF ONCOLOGY
- Fasting levels of hepatic p-S6 are increased in old mice
- (2014) Olga V Leontieva et al. CELL CYCLE
- Comparison of rapamycin schedules in mice on high-fat diet
- (2014) Olga V Leontieva et al. CELL CYCLE
- Rapamycin and Ageing: When, for How Long, and How Much?
- (2014) Matt Kaeberlein Journal of Genetics and Genomics
- Making new contacts: the mTOR network in metabolism and signalling crosstalk
- (2014) Mitsugu Shimobayashi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mice Fed Rapamycin Have an Increase in Lifespan Associated with Major Changes in the Liver Transcriptome
- (2014) Wilson C. Fok et al. PLoS One
- Single Rapamycin Administration Induces Prolonged Downward Shift in Defended Body Weight in Rats
- (2014) Mark Hebert et al. PLoS One
- Beneficial Metabolic Effects of Rapamycin Are Associated with Enhanced Regulatory Cells in Diet-Induced Obese Mice
- (2014) Kassem Makki et al. PLoS One
- Rapamycin Ameliorates Nephropathy despite Elevating Hyperglycemia in a Polygenic Mouse Model of Type 2 Diabetes, NONcNZO10/LtJ
- (2014) Peter C. Reifsnyder et al. PLoS One
- mTOR inhibition improves immune function in the elderly
- (2014) J. B. Mannick et al. Science Translational Medicine
- Koschei the immortal and anti-aging drugs
- (2014) M V Blagosklonny Cell Death & Disease
- Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium
- (2014) O V Leontieva et al. Cell Death & Disease
- Acute mTOR inhibition induces insulin resistance and alters substrate utilization in vivo
- (2014) Maximilian Kleinert et al. Molecular Metabolism
- Impaired glucose tolerance in rats fed low-carbohydrate, high-fat diets
- (2013) Maximilian Bielohuby et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- A Central Role for mTOR in Lipid Homeostasis
- (2013) Dudley W. Lamming et al. Cell Metabolism
- Duration of Rapamycin Treatment Has Differential Effects on Metabolism in Mice
- (2013) Yimin Fang et al. Cell Metabolism
- Conversion to Sirolimus Therapy in Kidney Transplant Recipients with New Onset Diabetes Mellitus after Transplantation
- (2013) Massimiliano Veroux et al. Clinical & Developmental Immunology
- mTOR in aging, metabolism, and cancer
- (2013) Marion Cornu et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Population response to information on reversibility of Type 2 diabetes
- (2013) S. Steven et al. DIABETIC MEDICINE
- The multifaceted role of mTORC1 in the control of lipid metabolism
- (2013) Stéphane J H Ricoult et al. EMBO REPORTS
- Mammalian Target of Rapamycin (mTOR) Inhibition with Rapamycin Improves Cardiac Function in Type 2 Diabetic Mice
- (2013) Anindita Das et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Treatment of Diabetes and Diabetic Complications With a Ketogenic Diet
- (2013) Charles V. Mobbs et al. JOURNAL OF CHILD NEUROLOGY
- TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists
- (2013) M V Blagosklonny Cell Death & Disease
- Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet
- (2013) O V Leontieva et al. Cell Death & Disease
- Alternative Perspectives on Aging in Caenorhabditis elegans: Reactive Oxygen Species or Hyperfunction?
- (2012) David Gems et al. ANTIOXIDANTS & REDOX SIGNALING
- Rapamycin-induced glucose intolerance: Hunger or starvation diabetes
- (2012) Mikhail V Blagosklonny CELL CYCLE
- Phase I Studies of Sirolimus Alone or in Combination with Pharmacokinetic Modulators in Advanced Cancer Patients
- (2012) E. E. W. Cohen et al. CLINICAL CANCER RESEARCH
- Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease
- (2012) Rebecca C. Schugar et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Rapamycin Ameliorates Age-Dependent Obesity Associated with Increased mTOR Signaling in Hypothalamic POMC Neurons
- (2012) Shi-Bing Yang et al. NEURON
- Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes
- (2012) Talib A. Hussain et al. NUTRITION
- Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
- (2012) D. W. Lamming et al. SCIENCE
- Of mice and men: The benefits of caloric restriction, exercise, and mimetics
- (2011) Evi M. Mercken et al. AGEING RESEARCH REVIEWS
- Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats
- (2011) N Deblon et al. BRITISH JOURNAL OF PHARMACOLOGY
- mTOR in podocyte function
- (2011) Min-Kan Lu et al. CELL CYCLE
- Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
- (2011) Markus Gödel et al. JOURNAL OF CLINICAL INVESTIGATION
- mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice
- (2011) Ken Inoki et al. JOURNAL OF CLINICAL INVESTIGATION
- Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity
- (2011) Shi-Bing Yang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Chronic Rapamycin Treatment Causes Glucose Intolerance and Hyperlipidemia by Upregulating Hepatic Gluconeogenesis and Impairing Lipid Deposition in Adipose Tissue
- (2010) V. P. Houde et al. DIABETES
- Insulin Sensitivity and Glucose Tolerance Are Altered by Maintenance on a Ketogenic Diet
- (2010) Kimberly P. Kinzig et al. ENDOCRINOLOGY
- The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats
- (2010) Maria Flaquer et al. LIFE SCIENCES
- mTORC1 controls fasting-induced ketogenesis and its modulation by ageing
- (2010) Shomit Sengupta et al. NATURE
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Sirolimus-Based Immunosuppression in Kidney Transplantation for Type 2 Diabetic Nephropathy
- (2010) M. Veroux et al. UROLOGIA INTERNATIONALIS
- Effects of long-term calorie restriction and endurance exercise on glucose tolerance, insulin action, and adipokine production
- (2009) Luigi Fontana et al. AGE
- Genetic variation in the murine lifespan response to dietary restriction: from life extension to life shortening
- (2009) Chen-Yu Liao et al. AGING CELL
- The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential
- (2009) Hiroyuki Mori et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Balancing needs and means: the dilemma of the β-cell in the modern world
- (2009) G. Leibowitz et al. DIABETES OBESITY & METABOLISM
- Larger Dosage Required for Everolimus than Sirolimus to Maintain Same Blood Concentration in Two Pancreatic Islet Transplant Patients with Tacrolimus
- (2009) Eriko Sato et al. Drug Metabolism and Pharmacokinetics
- Glucose Amplifies Fatty Acid-Induced Endoplasmic Reticulum Stress in Pancreatic β-Cells via Activation of mTORC1
- (2009) Etti Bachar et al. PLoS One
- Long-Term Treatment of Sirolimus but Not Cyclosporine Ameliorates Diabetic Nephropathy in the Rat
- (2009) Sandra Wittmann et al. TRANSPLANTATION
- Mammalian Target of Rapamycin and Diabetes: What Does the Current Evidence Tell Us?
- (2009) B. Vodenik et al. TRANSPLANTATION PROCEEDINGS
- Fasting in healthy subjects is associated with intrahepatic accumulation of lipids as assessed by1H-magnetic resonance spectroscopy
- (2008) Louise Moller et al. CLINICAL SCIENCE
- mTOR Inhibition by Rapamycin Prevents -Cell Adaptation to Hyperglycemia and Exacerbates the Metabolic State in Type 2 Diabetes
- (2008) M. Fraenkel et al. DIABETES
- The role of mTOR in the adaptation and failure of β-cells in type 2 diabetes
- (2008) G. Leibowitz et al. DIABETES OBESITY & METABOLISM
- Diabetes after Transplantation and Sirolimus: What's the Connection?
- (2008) M. Pavlakis et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sirolimus Is Associated with New-Onset Diabetes in Kidney Transplant Recipients
- (2008) O. Johnston et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Biphasic Response of Pancreatic -Cell Mass to Ablation of Tuberous Sclerosis Complex 2 in Mice
- (2008) Y. Shigeyama et al. MOLECULAR AND CELLULAR BIOLOGY
- Aging, Stem Cells, and Mammalian Target of Rapamycin: A Prospect of Pharmacologic Rejuvenation of Aging Stem Cells
- (2008) Mikhail V. Blagosklonny REJUVENATION RESEARCH
- Effect of mTOR inhibitor on body weight: from an experimental rat model to human transplant patients
- (2008) Jordi Rovira et al. TRANSPLANT INTERNATIONAL
- New-Onset Diabetes Mellitus After Kidney Transplantation: The Role of Immunosuppression
- (2008) M. Veroux et al. TRANSPLANTATION PROCEEDINGS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started